Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.

about

Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.

Item

http://www.wikidata.org/entity/Q38006917

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Menopausal hormone therapy (MH ...... considering the future of MHT.

@en

type

Item

label

Menopausal hormone therapy (MH ...... considering the future of MHT.

@en

prefLabel

Menopausal hormone therapy (MH ...... considering the future of MHT.

@en

P1476

Menopausal hormone therapy (MH ...... considering the future of MHT.

@en

P2093

Ellena A Anagnostis

http://www.w3.org/2001/XMLSchema#string

P2860

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.

Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Hormone therapy to prevent disease and prolong life in postmenopausal women.

P304

324-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0897190012442064

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22550160

http://www.w3.org/2001/XMLSchema#string